43 results
DEF 14C
SCNX
Scienture Holdings, Inc.
28 Aug 24
Information statement
4:05pm
representatives and omnichannel marketing to effectively reach Health Care Providers (“HCPs”) and offer patient education. Scienture’s promotional efforts … than nine months of term remaining.
Biosimilars and Exclusivity
The Patient Protection and Affordable Care Act, as amended by the Health Care
PRE 14C
SCNX
Scienture Holdings, Inc.
15 Aug 24
Preliminary information
9:57pm
to effectively reach Health Care Providers (“HCPs”) and offer patient education. Scienture’s promotional efforts are expected to further include … .
Biosimilars and Exclusivity
The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010
8-K
EX-2.1
SCNX
Scienture Holdings, Inc.
31 Jul 24
TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million
5:25pm
family members, caregivers or advocates, physicians and other health care professionals, clinical trial investigators, researchers, pharmacists … or advocates, physicians and other health care professionals, clinical trial investigators, researchers, pharmacists) that interact with MEDS or any of its
8-K
EX-2.1
SCNX
Scienture Holdings, Inc.
16 Feb 24
Entry into a Material Definitive Agreement
5:05pm
U.S.C. §§ 1396-1396w-5 (the Medicaid statute), the Federal Health Care Program Anti-Kickback Statute, 42 U.S.C. § 1320a-7b(b), the Anti-Kickback Act … for or reimbursement of products, other health care goods and items, or healthcare services, quality and safety, the corporate practice of medicine
425
EX-2.1
3yks3agfb5rew
14 Jul 23
Business combination disclosure
5:08pm
8-K
EX-2.1
4zxsi96e
14 Jul 23
TRxADE HEALTH, Inc. Amends Definitive Merger
5:07pm
425
EX-2.1
yrul3q
30 Jun 23
Business combination disclosure
9:25am
8-K
EX-2.1
e8oc5wblfh23g5bc
30 Jun 23
Superlatus, Inc. and TRxADE HEALTH, Inc. Sign Definitive Merger
9:25am
424B3
v07znn5zvdsmzbxe
8 Dec 22
Prospectus supplement
5:05pm
424B5
g6tdg
23 Aug 22
Prospectus supplement for primary offering
4:01pm
8-K/A
517o1g
11 Mar 22
Entry into a Material Definitive Agreement
4:35pm
8-K
EX-10.2
6887o1 bmv3rj1p5obft
4 Mar 22
Entry into a Material Definitive Agreement
4:05pm
8-K
bof88g
4 Mar 22
Entry into a Material Definitive Agreement
4:05pm